港股異動丨香港本地零售股逆勢普漲 香港將於2月26日展開新冠疫苗接種計劃
格隆匯2月19日丨香港本地零售股逆勢普漲,周大福和周生生漲近6%,佐丹路國際和莎莎國際漲近4%。香港特區政府公務員事務局局長聶德權18日表示,香港新冠疫苗接種計劃將於2月23日起接受網上預約,26日起開展,首先為五個高危組別人士接種。他透露,約100萬劑科興疫苗19日抵港,另一款“復必泰”疫苗會在月底前抵達。香港特區政府衞生署衞生防護中心18日公佈,截至當日零時,香港新增8例新冠肺炎確診病例。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.